FAQ

Lymphoma, Intermediate-Grade

Known as: Intermediate-Grade Lymphomas, Lymphoma, Intermediate Grade, Lymphomas, Intermediate-Grade 
A type of lymphoma that grows and spreads quickly and has severe symptoms. Also called aggressive lymphoma and high-grade lymphoma.

Topic mentions per year

Topic mentions per year

1984-2014
0246819842014

Related topics

Related topics

2 relations

Broader (1)

Lymphoma, Non-Hodgkin
Neoplastic Cell

Related mentions per year

Related mentions per year

1941-2018
19401960198020002020
Lymphoma, Intermediate-Grade
Lymphoma, Non-Hodgkin
Neoplastic Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.
PURPOSE To assess the outcome of high-dose therapy with autologous stem-cell support in patients with histologic transformation… (More)
Is this relevant?
1999
1999
The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma
We analyzed a group of 51 patients with primary refractory and relapsed intermediate-grade lymphoma (IGL) from the time of… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
PURPOSE To investigate the use of a nonmyeloablative fludarabine-based preparative regimen to produce sufficient… (More)
Is this relevant?
1997
1997
Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial.
In order to determine the activity of paclitaxel in patients with relapsed or refractory non-Hodgkin's lymphoma (NHL), we… (More)
Is this relevant?
1997
1997
Evaluation of continuous-infusion gallium nitrate and hydroxyurea in combination for the treatment of refractory non-Hodgkin's lymphoma.
Based on preclinical studies demonstrating synergy between gallium and hydroxyurea, we evaluated the efficacy and toxicity of… (More)
Is this relevant?
1996
1996
Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.
PURPOSE To evaluate outcomes and identify prognostic factors in allogeneic bone marrow transplantation in patients with end-stage… (More)
Is this relevant?
1995
1995
Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.
PURPOSE To determine whether modifying the standard regimen of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP… (More)
Is this relevant?
1994
1994
Follicular large-cell lymphoma: intermediate or low grade?
PURPOSE To evaluate the benefit of anthracycline-based chemotherapy, identify prognostic factors, and determine the value of the… (More)
Is this relevant?
1989
1989
High-grade non-Hodgkin lymphoma relapsing as low-grade follicular lymphoma: so-called downgraded lymphoma.
Evolution of low-grade Non-Hodgkin Lymphoma (NHL) into a more aggressive neoplasm is a common, well-documented event in NHL. The… (More)
Is this relevant?
1984
1984
Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon.
We report the results of a trial of recombinant leukocyte A interferon in previously treated patients with non-Hodgkin's lymphoma… (More)
Is this relevant?